Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Engineered antibody CH2 domains binding to nucleolin: Isolation, characterization and improvement of aggregation

Journal Article · · Biochemical and Biophysical Research Communications
 [1];  [2];  [3];  [4];  [5];  [3]
  1. College of Life Science, Xiamen University, Xiamen, Fujian (China)
  2. CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei (China)
  3. Faculty of Health Sciences, University of Macau, Taipa, Macau (China)
  4. Department of General Surgery, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang (China)
  5. Protein Interaction Section, Cancer Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD (United States)

Smaller recombinant antibody fragments are now emerging as alternatives of conventional antibodies. Especially, immunoglobulin (Ig) constant CH2 domain and engineered CH2 with improved stability are promising as scaffolds for selection of specific binders to various antigens. We constructed a yeast display library based on an engineered human IgG1 CH2 scaffold with diversified loop regions. A group of CH2 binders were isolated from this yeast display library by panning against nucleolin, which is a tumor-associated antigen involved in cell proliferation, tumor cell growth and angiogenesis. Out of 20 mutants, we selected 3 clones exhibiting relatively high affinities to nucleolin on yeasts. However, recombinant CH2 mutants aggregated when they were expressed. To find the mechanism of the aggregation, we employed computational prediction approaches through structural homology models of CH2 binders. The analysis of potential aggregation prone regions (APRs) and solvent accessible surface areas (ASAs) indicated two hydrophobic residues, Val{sub 264} and Leu{sub 309}, in the β-sheet, in which replacement of both charged residues led to significant decrease of the protein aggregation. The newly identified CH2 binders could be improved to use as candidate therapeutics or research reagents in the future. - Highlights: • Novel engineered CH2 domains to nucleolin were identified from the yeast display CH2-based library. • Aggregation prone regions (APRs) were predicted through structural homology models CH2 domains. • The replacement of two hydrophobic residues in APRs significantly led to decrease of the CH2 aggregation.

OSTI ID:
22696946
Journal Information:
Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 2 Vol. 485; ISSN BBRCA9; ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

A novel interation of nucleolin with Rad51
Journal Article · Fri May 26 00:00:00 EDT 2006 · Biochemical and Biophysical Research Communications · OSTI ID:20798968

Mouse nucleolin binds to 4.5S RNAH, a small noncoding RNA
Journal Article · Thu Jan 03 23:00:00 EST 2008 · Biochemical and Biophysical Research Communications · OSTI ID:21033040